C12 DAPAGLIFLOZIN INCREASES PAMPK AND REDUCES MYOCARDIAL AND RENAL NF–KB EXPRESSION IN PRECLINICAL MODELS OF SHORT–TERM DOXORUBICIN CARDIOTOXICITY THROUGH MYD–188 AND NLRP3 PATHWAYSVincenzo Quagliariello, Nicola Maurea, Antonio Luciano et al.|European Heart Journal Supplements|2023Cited by 3
Dapagliflozin improves radial and longitudinal strain, increases pAMPK and reduces myocardial and renal NF-kB expression in preclinical models of doxorubicin cardiotoxicity through NLRP3 and Myd-88Nicola Maurea, Vincenzo Quagliariello, Maria Laura Canale et al.|European Heart Journal - Cardiovascular Imaging|2023Cited by 1